Centrifugal Blood Pump Market

By Motor Type;

Electronic and Mechanical

By Applications;

Cardiac Surgery and Cardiopulmonarypass

By Distribution Channel;

Direct Sales and Online Retail

By End User;

Hospitals, Specialty Clinics, and Ambulatory Surgical Centers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn461475444 Published Date: August, 2025 Updated Date: September, 2025

Centrifugal Blood Pump Market Overview

Centrifugal Blood Pump Market (USD Million)

Centrifugal Blood Pump Market was valued at USD 76.33 million in the year 2024. The size of this market is expected to increase to USD 111.03 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.5%.


Centrifugal Blood Pump Market

*Market size in USD million

CAGR 5.5 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.5 %
Market Size (2024)USD 76.33 Million
Market Size (2031)USD 111.03 Million
Market ConcentrationMedium
Report Pages337
76.33
2024
111.03
2031

Major Players

  • Novartis AG
  • Allergan, Merck & Co., Inc
  • Akorn, Inc
  • Bausch & Lomb Incorporated
  • Teva Pharmaceuticals
  • Pfizer
  • Santen

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Centrifugal Blood Pump Market

Fragmented - Highly competitive market without dominant players


The centrifugal blood pump market is expanding steadily as demand for reliable cardiovascular support devices rises. These pumps are essential in cardiopulmonary bypass procedures and extracorporeal circulation, providing safe and consistent blood flow. Currently, nearly 64% of heart surgeries utilize centrifugal pumps to support patient outcomes.

Enhancing Patient Outcomes and Safety
The focus on biocompatible and efficient blood-handling systems is accelerating adoption. Around 59% of hospitals report lower complication rates with centrifugal pumps compared to traditional alternatives. Their ability to reduce blood trauma while improving circulation efficiency is reinforcing their widespread use.

Innovations in Pump Technology
Technological advancements are shaping the industry, with magnetically levitated impellers, advanced sensors, and compact structures gaining traction. Nearly 46% of new models are designed to minimize hemolysis and provide enhanced flow regulation. These innovations are improving treatment standards and driving clinical acceptance.

Broader Use in Critical Care Settings
Beyond surgery, centrifugal blood pumps are increasingly integrated into ECMO systems and intensive care treatments. More than 52% of critical care units employ these pumps for patients with severe cardiac or respiratory challenges. Their expanding role across healthcare segments underscores their market potential.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Motor Type
    2. Market Snapshot, By Applications
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Centrifugal Blood Pump Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing demand for cardiac surgeries
        2. Advancements in extracorporeal life support (ECLS) technology
        3. Development of cost-effective blood pumps
      2. Restraints
        1. High cost of blood pumps
        2. Reimbursement concerns
        3. Potential complications
      3. Opportunities
        1. Emerging markets
        2. Technological advancements
        3. Growing minimally invasive procedures
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Centrifugal Blood Pump Market, By Motor Type, 2021 - 2031 (USD Million)
      1. Electronic
      2. Mechanical
    2. Centrifugal Blood Pump Market, By Applications, 2021 - 2031 (USD Million)

      1. Cardiac Surgery

      2. Cardiopulmonarypass

    3. Centrifugal Blood Pump Market, By Distribution Channel, 2021 - 2031 (USD Million)

      1. Direct Sales

      2. Online Retail

    4. Centrifugal Blood Pump Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
    5. Centrifugal Blood Pump Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Novartis AG
      2. Allergan
      3. Merck & Co., Inc
      4. Akorn, Inc
      5. Bausch & Lomb Incorporated
      6. Teva Pharmaceuticals
      7. Pfizer
      8. Santen
  7. Analyst Views
  8. Future Outlook of the Market